Behavioral Determinants of Older Adults' and Caregivers' Willingness to Deprescribe: A Systematic Review

Overview

Journal Public Health Nurs

Date 2024 Dec 31

PMID 39740058

Authors

Sara Alves Jorge

Stephan Van den Broucke

Ruth-Janet Koumba Maguena

Anne Spinewine

Affiliations

Soon will be listed here.

Abstract

Background: Deprescribing is a strategy to optimize medication use and to prevent medication harm. Despite the fact that behavioral theories have been shown to be useful in explaining health behaviors, the literature on deprescribing relies almost exclusively on attitudes as an explanatory factor for deprescribing behavior. This study systematically reviews the literature that made explicit use of the constructs included in health behavior theories (HBTs) to explain older adults' and informal caregivers' deprescribing behavior and outcomes.

Methods: Studies were screened from five electronic databases by two reviewers. Quantitative interventional and non-interventional studies applying at least one HBTs or construct from these theories to older adults' or informal caregiver' intention or behavior to deprescribe, were included. Studies that used the patients' attitudes toward deprescribing (PATD) questionnaire or its revised version were excluded.

Results: A total of 11 non-interventional studies and 11 interventional studies were identified, seven of which applied HBTs, and the other 15 used constructs from the HBTs. Health literacy and locus of control were identified as moderator variables. Only two studies targeted informal caregivers' deprescribing intentions or behavior.

Conclusions: HBTs are not systematically used. However, combining the main HBT constructs reported in the literature offers a better explanation of the (intention to) engage in deprescribing.

Trail Registration: The study protocol (ID: CRD42022378157) was published on PROSPERO.

References

Sake F, Wong K, Bartlett D, Saini B . Benzodiazepine use risk: Understanding patient specific risk perceptions and medication beliefs. Res Social Adm Pharm. 2019; 15(11):1317-1325. DOI: 10.1016/j.sapharm.2018.12.007. View

Linsky A, Simon S, Bokhour B . Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2014; 98(2):220-5. DOI: 10.1016/j.pec.2014.11.010. View

Seewoodharry M, Khunti K, Davies M, Gillies C, Seidu S . Attitudes of older adults and their carers towards de-prescribing: A systematic review. Diabet Med. 2022; 39(7):e14801. DOI: 10.1111/dme.14801. View

Doekhie K, Buljac-Samardzic M, Strating M, Paauwe J . Elderly patients' decision-making embedded in the social context: a mixed-method analysis of subjective norms and social support. BMC Geriatr. 2020; 20(1):53. PMC: 7017481. DOI: 10.1186/s12877-020-1458-7. View

Reeve E, Low L, Hilmer S . Attitudes of Older Adults and Caregivers in Australia toward Deprescribing. J Am Geriatr Soc. 2019; 67(6):1204-1210. DOI: 10.1111/jgs.15804. View

Chock Y, Wee Y, Gan S, Teoh K, Ng K, Lee S . How Willing Are Patients or Their Caregivers to Deprescribe: a Systematic Review and Meta-analysis. J Gen Intern Med. 2021; 36(12):3830-3840. PMC: 8642501. DOI: 10.1007/s11606-021-06965-5. View

Evrard P, Petein C, Beuscart J, Spinewine A . Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework. Implement Sci. 2022; 17(1):41. PMC: 9264665. DOI: 10.1186/s13012-022-01206-7. View

Linsky A, Gellad W, Linder J, Friedberg M . Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework. J Am Geriatr Soc. 2019; 67(10):2018-2022. PMC: 6800794. DOI: 10.1111/jgs.16136. View

Rababa M, Rababah A . Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors. BMC Geriatr. 2020; 20(1):431. PMC: 7596985. DOI: 10.1186/s12877-020-01844-w. View

10.

Reeve E, Wolff J, Skehan M, Bayliss E, Hilmer S, Boyd C . Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States. JAMA Intern Med. 2018; 178(12):1673-1680. PMC: 6583614. DOI: 10.1001/jamainternmed.2018.4720. View

11.

Campbell N, Holden R, Tang Q, Boustani M, Teal E, Hillstrom J . Multicomponent behavioral intervention to reduce exposure to anticholinergics in primary care older adults. J Am Geriatr Soc. 2021; 69(6):1490-1499. PMC: 8959093. DOI: 10.1111/jgs.17121. View

12.

Belleville G, Morin C . Hypnotic discontinuation in chronic insomnia: impact of psychological distress, readiness to change, and self-efficacy. Health Psychol. 2008; 27(2):239-48. DOI: 10.1037/0278-6133.27.2.239. View

13.

McCann C, McCauley C, Harkin D . Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study. J Adv Nurs. 2023; 80(6):2500-2511. DOI: 10.1111/jan.15995. View

14.

Lynch T, Ryan C, Presseau J, Foster D, Huff C, Bennett K . Development and validation of a theory-based questionnaire examining barriers and facilitators to discontinuing long-term benzodiazepine receptor agonist use. Res Social Adm Pharm. 2023; 20(2):163-171. DOI: 10.1016/j.sapharm.2023.10.015. View

15.

Rozsnyai Z, Jungo K, Reeve E, Poortvliet R, Rodondi N, Gussekloo J . What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey. BMC Geriatr. 2020; 20(1):435. PMC: 7602330. DOI: 10.1186/s12877-020-01843-x. View

16.

Linsky A, Simon S, Stolzmann K, Meterko M . Patient Perceptions of Deprescribing: Survey Development and Psychometric Assessment. Med Care. 2016; 55(3):306-313. PMC: 6788283. DOI: 10.1097/MLR.0000000000000642. View

17.

Grimshaw J, Patey A, Kirkham K, Hall A, Dowling S, Rodondi N . De-implementing wisely: developing the evidence base to reduce low-value care. BMJ Qual Saf. 2020; 29(5):409-417. PMC: 7229903. DOI: 10.1136/bmjqs-2019-010060. View

18.

Barker T, Stone J, Sears K, Klugar M, Leonardi-Bee J, Tufanaru C . Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2022; 21(3):478-493. DOI: 10.11124/JBIES-22-00125. View

19.

Martin P, Tannenbaum C . Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment. BMC Geriatr. 2017; 17(1):37. PMC: 5282809. DOI: 10.1186/s12877-017-0432-5. View

20.

Rogers R . A Protection Motivation Theory of Fear Appeals and Attitude Change1. J Psychol. 2017; 91(1):93-114. DOI: 10.1080/00223980.1975.9915803. View